这是参与癌症治疗的激动人心的时刻。基于对癌症分子方面的更深入了解，出现了新的治疗干预机会，这些机会可以有效地“靶向治疗”。这些新疗法与经典的化疗药物截然不同，它们为针对个体患者的肿瘤量身定制的真正选择性癌症疗法提供了前景。癌症药理学在药物开发中起关键作用。在实验室和诊所中，癌症药理学都必须通过建立实验模型和靶向方法来适应不断变化的药物开发方式。该计划旨在为您提供现代癌症药理学的“最新”课程，以满足雇主的需求，并为您提供可用的癌症药物和新的癌症治疗方法的专家意见。
This is an exciting time to be involved in cancer therapeutics. Based upon a greater understanding of the molecular aspects of cancer, new opportunities for therapeutic intervention have emerged that are effectively 'target orientated'. These new therapeutics are quite distinct from the classical chemotherapeutic agents and they offer the prospect of truly selective cancer therapies that are tailored towards the individual patient's tumour. Cancer pharmacology plays a key role in drug development. In both the laboratory and the clinic, cancer pharmacology has had to adapt to the changing face of drug development by establishing experimental models and target orientated approaches. The programme is designed to provide you with a 'state-of-the-art' course in modern cancer pharmacology that meets the demand of employers and provides an expert view of the available cancer medicines and the development of new cancer therapies. It promotes advanced scholarship within specialised areas at the same time as the development of key transferable skills (in IT, communication, and time management) and research techniques. The taught component of the course provides the in-depth knowledge and skills necessary to work in cancer research, and is delivered across 2 semesters through lectures, workshops, practicals and 1-to-1 tutorials with ICT staff. You will then join one of our research teams to complete the MSc research project.